All News about Silo Pharma Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5379.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/20/psyched.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/15/psychedelic_chemistry_olia_danilevich_by_pexels_-_copy.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/03/03/10_psychedelics_ceos_2_shutterstock_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3659.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3563.jpeg?width=1200&height=800&fit=crop)
BioMedNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Alzheimer’s
February 13, 2023
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png)
Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s
February 13, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/02/03/mdma_investigation_blue_planet_studio_and_andrei_askirka_by_shutterstock.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Thursday's After-Market Session
February 02, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_2287.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Intraday Session
February 02, 2023
Via Benzinga
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands IP Portfolio with New USPTO Patent
February 02, 2023
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png)
![](https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png)
Silo Pharma Announces Stock Repurchase Program
January 31, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_415.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/03/image26.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.